迈之灵是一种以欧洲马栗树籽提取物为主要成分的药品，其作用为：降低血管通透性、增加静脉回流、减轻静脉淤血症状、增加血管弹性、增加血管张力、抗氧自由基作用。
迈之灵片 Aescuven forte Tablets
Conclussion To ischemic type of CRVO ,it is an important method to apply PRP to prevent and treat neovascularization and serious complications. The application of Aescuven fort can shorten the absorbed time of hemorrhage,edema and effusion.
结论:对于缺血性视网膜中央静脉阻塞,采用全视网膜光凝术预防和治疗新生血管是防止严重并发症的重要手段,迈之灵的联合应用可以缩短眼底出血、水肿和渗出的消退时间。
参考来源 - 氪激光联合药物迈之灵治疗视网膜中央静脉阻塞的临床研究·2,447,543篇论文数据，部分数据来源于NoteExpress
目的探讨迈之灵在软组织损伤后创伤性水肿的应用价值及疗效分析。
Objective To discuss value and effect of aescvev forte on soft tissue injury.
方法对接诊的124例软组织损伤患者，61例预防应用迈之灵（观察组），63例未应用迈之灵（对照组）。
Methods Of 124 patients with soft tissue injury, 61 cases were treated with aescven forte(observe group) and 63 cases were treated without aescven forte(control group).
应用推荐